These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21242444)

  • 1. Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation.
    Kucirka LM; Ros RL; Subramanian AK; Montgomery RA; Segev DL
    Arch Surg; 2011 Jan; 146(1):41-5. PubMed ID: 21242444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informing candidates for solid-organ transplantation about donor risk factors.
    Halpern SD; Shaked A; Hasz RD; Caplan AL
    N Engl J Med; 2008 Jun; 358(26):2832-7. PubMed ID: 18579820
    [No Abstract]   [Full Text] [Related]  

  • 3. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
    Ahn J; Cohen SM
    Liver Transpl; 2008 Nov; 14(11):1603-8. PubMed ID: 18975294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians.
    Ison MG; Stosor V
    Clin Transplant; 2009; 23(6):866-73. PubMed ID: 19473202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections transmitted by transplantation.
    Morris MI; Fischer SA; Ison MG
    Infect Dis Clin North Am; 2010 Jun; 24(2):497-514. PubMed ID: 20466280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
    Ison MG; Friedewald JJ
    Liver Transpl; 2009 May; 15(5):561; author reply 562. PubMed ID: 19399730
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).
    Davis AR
    Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of donor high-risk social behaviors on recipient survival in cardiac transplantation.
    Xu DS; Hartman D; Ludrosky K; Campbell J; Starling RC; Taylor DO; Smedira NG; Gonzalez-Stawinski GV
    Transplantation; 2010 Apr; 89(7):873-8. PubMed ID: 20090571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections transmitted from donors to recipients following organ transplantation.
    Rao YG; Mirza DF
    Natl Med J India; 2005; 18(4):189-94. PubMed ID: 16252549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organ donation and risks of infections].
    Peigue-Lafeuille H
    Pathol Biol (Paris); 2011 Oct; 59(5):243-4. PubMed ID: 19896292
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethics and practice in organ transplantation in patients infected with human immunodeficiency virus.
    Ricci-Murphy JA; Ress B; Axt C
    Crit Care Nurse; 2000 Apr; 20(2):85-91. PubMed ID: 11873755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadaver donor screening for infectious agents in solid organ transplantation.
    Delmonico FL
    Clin Infect Dis; 2000 Sep; 31(3):781-6. PubMed ID: 11017830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV transmitted from a living organ donor--New York City, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(10):297-301. PubMed ID: 21412210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor.
    Simonds RJ; Holmberg SD; Hurwitz RL; Coleman TR; Bottenfield S; Conley LJ; Kohlenberg SH; Castro KG; Dahan BA; Schable CA
    N Engl J Med; 1992 Mar; 326(11):726-32. PubMed ID: 1738377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplant tourism and donor-derived parasitic infections.
    Kotton CN
    Transplant Proc; 2011; 43(6):2448-9. PubMed ID: 21839290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Apr; 52(13):273-4, 276. PubMed ID: 12729075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology and prevention of donor-derived infections.
    Ison MG
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):234-41. PubMed ID: 19576553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of hepatitis C virus by organ transplantation.
    Pereira BJ; Milford EL; Kirkman RL; Levey AS
    N Engl J Med; 1991 Aug; 325(7):454-60. PubMed ID: 1649402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus: Prevention, screening, and interpretation of assays.
    Albeldawi M; Ruiz-Rodriguez E; Carey WD
    Cleve Clin J Med; 2010 Sep; 77(9):616-26. PubMed ID: 20810872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.